Sutro Biopharma Appoints Dr. Hans-Peter Gerber as Chief Scientific Officer SOUTH SAN FRANCISCO, Calif., September 19, 2023 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format...
Sutro Biopharma
310 Utah Ave
Suite 150
South San Francisco, CA 94080
650.392.8412
